SCHEMBL1004337

SCHEMBL1004337

COC(=O)c1cccc2oc(N)nc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.57
HTR3A P46098 1/20 0.49
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
CFTR P13569 1/20 0.47
KDM4E B2RXH2 5/20 0.46
HPGD P15428 3/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
PKN1 Q16512 1/20 0.45
PKN2 Q16513 1/20 0.45
ATM Q13315 3/20 0.45
GAA P10253 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
TRPA1 O75762 1/20 0.41
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1398896 0.83 TOP2A (0.59) TOP2AALDH1A1HSD17B10CFTRKDM4E
SCHEMBL1005898 0.82 TOP2A (0.57) TOP2AALDH1A1HSD17B10CFTRKDM4E
SCHEMBL1121666 0.82 TOP2A (0.57) TOP2AALDH1A1HSD17B10CFTRKDM4E
SCHEMBL3990631 0.81 MAOB (0.56) TOP2AHTR3AALDH1A1HSD17B10KDM4E
SCHEMBL1005701 0.81 TOP2A (0.56) TOP2AHTR3AALDH1A1HSD17B10CFTR
SCHEMBL1006408 0.79 TOP2A (0.55) TOP2AHTR3AALDH1A1HSD17B10KDM4E
SCHEMBL7440762 0.79 TOP2A (0.55) TOP2AALDH1A1HSD17B10CFTRKDM4E
SCHEMBL7721972 0.79 TOP2A (0.55) TOP2AALDH1A1HSD17B10KDM4EHPGD
SCHEMBL9178689 0.78 TOP2A (0.54) TOP2AALDH1A1HSD17B10KDM4EHPGD
SCHEMBL4307487 0.78 TOP2A (0.54) TOP2AALDH1A1HSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
EP-2061460-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS Albany Molecular Research, Inc. (US) 2009-05-27 EP disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed
WO-2008019372-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS ALBANY MOLECULAR RESEARCH, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS HTR3E, HTR3C, HTR3A TOP2A 323/4885HTR3A 3/4885ALDH1A1 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.